Search results for "actors"

showing 10 items of 11323 documents

Hepatitis C virus infection in hemodialyzed patients.

2007

In spite of our present improved knowledge of the epidemiology and pathways of contamination of the hepatitis C virus (HCV), infection still remains a public health problem. One category of patients who have suffered greatly from the consequences of HCV infection is certainly that of hemodialysis patients. In the past, in fact, their need for transfusions exposed these patients to infection and, as a result, subjects on dialysis for over 15 years are today paying the price for those inevitable transfusions, as the virus and its pathways of contagion were unknown then. However, still today, albeit at a much lower prevalence, even subjects with a shorter dialysis age present a higher prevalen…

medicine.medical_specialtymedicine.medical_treatmentHepatitis C virusPopulationBiomedical EngineeringMedicine (miscellaneous)Bioengineering030204 cardiovascular system & hematologymedicine.disease_causeAsymptomaticAntiviral AgentsBiomaterials03 medical and health scienceschemistry.chemical_compoundLiver disease0302 clinical medicineRenal DialysisRisk FactorsInternal medicinemedicineHumanseducationDialysiseducation.field_of_studybusiness.industryRibavirinMortality rateTransfusion ReactionGeneral Medicinemedicine.diseaseHepatitis Cchemistry030220 oncology & carcinogenesisImmunologyHemodialysismedicine.symptombusinessThe International journal of artificial organs
researchProduct

Modulation of IL-2, IFN-γ, TNF-α and IL-4 production in mice of different ages by thymopentin

1992

The effect of an immunomodulator drug thymopentin (TP5) on the production of various cytokines (IFN-gamma, IL-2, IL-4, TNF-alpha) in mice of different ages has been studied. TP5 enhanced IL-2, TNF-alpha and IFN-gamma production but reduced the IL-4 secretion by splenocytes from aged mice (greater than 120 week old) in vitro. However, it had no effect on the IL-2, IFN-gamma, TNF-alpha or IL-4 production by splenocytes from young and adult mice. TP5 injected subcutaneously was able to induce high levels of IL-2 production by splenocytes from all groups of mice. The TP5 effect on TNF-alpha and IFN-gamma was similar, even though it was significant only in old mice. Furthermore, TP5 was able to …

medicine.medical_specialtymedicine.medical_treatmentImmunologyMitogen stimulationInterferon-gammaMiceT-Lymphocyte SubsetsInternal medicinemedicineSplenocyteAnimalsThymopentinSecretionLymphocytesInterleukin 4PharmacologyMice Inbred BALB CTumor Necrosis Factor-alphabusiness.industryAge FactorsIn vitroCytokineEndocrinologyInterleukin-2FemaleInterleukin-4Thymopentinbusinessmedicine.drugInternational Journal of Immunopharmacology
researchProduct

The diagnosis of and treatment recommendations for anxiety disorders.

2014

Anxiety disorders (panic disorder/agoraphobia, generalized anxiety disorder, social phobia, and specific phobias) are the most common mental illnesses. For example, the 12-month prevalence of panic disorder/agoraphobia is 6%.This guideline is based on controlled trials of psychotherapy and pharmacotherapy, retrieved by a systematic search for original articles that were published up to 1 July 2013. Experts from 20 specialty societies and other organizations evaluated the evidence for each treatment option from all available randomized clinical trials and from a synthesis of the recommendations of already existing international and German guidelines.403 randomized controlled trials were eval…

medicine.medical_specialtymedicine.medical_treatmentMEDLINElaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled triallawRisk FactorsmedicineHumansIntensive care medicinePsychiatryPsychodynamic psychotherapyPsychotropic Drugsbusiness.industryGeneral MedicineGuidelineClinical Practice GuidelineAnxiety Disorders030227 psychiatry3. Good healthCognitive behavioral therapyPsychotherapyNeurologyPractice Guidelines as TopicAnxietymedicine.symptomReuptake inhibitorbusiness030217 neurology & neurosurgeryDeutsches Arzteblatt international
researchProduct

Improved femoral neck BMD in older Finnish women between 2002 and 2010.

2013

Abstract Purpose The number of hip fractures among Finns over 50-years of age rose constantly between 1970 and 1997, but since then, there has been a nationwide decline in incidence of hip fractures. One possible explanation, although not the only one, for the declining fracture rates, could be improved bone mineral density (BMD). The aim of this study was to evaluate differences in femoral neck BMD between older Finnish women born about a decade apart. Methods We compared the baseline data of two population-based samples of home-dwelling 70–80-year-old women who were initially recruited in exercise intervention studies ( N  = 216 in Cohort1, and N  = 389 in Cohort 2). Femoral neck BMD was …

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisPopulationGeneral Biochemistry Genetics and Molecular BiologyCohort StudiesBone DensitymedicineHumanseducationFinlandOsteoporosis PostmenopausalFemoral neckAgedBone mineralAged 80 and overeducation.field_of_studyAnalysis of Variancebusiness.industryFemur NeckHip FracturesIncidence (epidemiology)IncidenceAge FactorsObstetrics and Gynecologyta3141Baseline datamedicine.diseaseBody Heightmedicine.anatomical_structureCohortPhysical therapyFemaleHormone therapybusinessDemographyMaturitas
researchProduct

Chronic kidney disease and dyslipidaemia

2016

Chronic kidney disease (CKD) has to be considered as a high, or even very high risk cardiovascular risk condition, since it leads to an increase in cardiovascular mortality that continues to increase as the disease progresses. An early diagnosis of CKD is required, together with an adequate identification of the risk factors, in order to slow down its progression to more severe states, prevent complications, and to delay, whenever possible, the need for renal replacement therapy. Dyslipidaemia is a factor of the progression of CKD that increases the risk in developing atherosclerosis and its complications. Its proper control contributes to reducing the elevated cardiovascular morbidity and …

medicine.medical_specialtymedicine.medical_treatmentRenal functionDisease030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumans030212 general & internal medicineRenal replacement therapyRenal Insufficiency ChronicIntensive care medicineDyslipidemiasGeneral Environmental ScienceCardiovascular mortalitybusiness.industryAnticholesteremic AgentsGeneral EngineeringCholesterol LDLmedicine.diseaseRenal Replacement TherapyCardiovascular DiseasesRenal transplantDisease ProgressionPhysical therapyGeneral Earth and Planetary SciencesHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessVery high riskDyslipidemiaKidney diseaseClínica e Investigación en Arteriosclerosis (English Edition)
researchProduct

Thrombolytic therapy for submassive pulmonary embolism.

2012

Approximately 10% of all patients with acute pulmonary embolism (PE) die within the first three months after diagnosis. However, PE is not universally life-threatening, but covers a wide spectrum of clinical severity and death risk. Thrombolytic treatment is indicated patients with acute massive PE who are at high risk for early death, i.e. those patients who present with arterial hypotension and shock. On the other hand, low molecular-weight heparin or fondaparinux is adequate treatment for most normotensive patients with PE. Recombinant tissue plasminogen activator, given as 100 mg infusion over 2 h, is the treatment of choice for patients with PE, although older regimens using urokinase …

medicine.medical_specialtymedicine.medical_treatmentStreptokinaseVentricular Dysfunction RightClinical Biochemistry030204 cardiovascular system & hematologyFondaparinuxlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialFibrinolytic AgentslawPolysaccharidesRisk FactorsInternal medicinemedicineHumansStreptokinaseThrombolytic Therapy030212 general & internal medicineIntensive care medicineUrokinaseClinical Trials as Topicbusiness.industryHeparinThrombolysisHeparin Low-Molecular-Weightmedicine.diseaseUrokinase-Type Plasminogen ActivatorTroponin3. Good healthPulmonary embolismRadiographyOncologyFondaparinuxTissue Plasminogen ActivatorAcute DiseaseCardiologybusinessPulmonary EmbolismBiomarkersmedicine.drugCohort studyBest practiceresearch. Clinical haematology
researchProduct

An International, Multicenter Retrospective Observational Study to Assess Technical Success and Clinical Outcomes of Patients Treated with an Endovas…

2022

Introduction: Type III endoleaks post-endovascular aortic aneurysm repair (EVAR) warrant treatment because they increase pressure within the aneurysm sac leading to increased rupture risk. The treatment may be difficult with regular endovascular devices. Endovascular aneurysm sealing (EVAS) might provide a treatment option for type III endoleaks, especially if located near the flow divider. This study aims to analyze clinical outcomes of EVAS for type III endoleaks after EVAR. Methods: This is an international, retrospective, observational cohort study including data from 8 European institutions. Results: A total of 20 patients were identified of which 80% had a type IIIb endoleak and the r…

medicine.medical_specialtymedicine.medical_treatmentTechnical successClinical Investigationsendoleak030204 cardiovascular system & hematologyProsthesis DesignEndovascular aneurysm repair030218 nuclear medicine & medical imagingendovascular aneurysm repair03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicineAneurysmabdominal aortic aneurysmRisk FactorsmedicineMANAGEMENTHumansabdominal aortic aneurysm; aneurysm; endoleak; endovascular aneurysm repair; reinterventionRadiology Nuclear Medicine and imagingRupture riskcardiovascular diseasesRetrospective StudiesreinterventionREPAIRAortic aneurysm repairABDOMINAL AORTIC-ANEURYSMSIncrease pressurebusiness.industryEndovascular ProceduresRetrospective cohort studymedicine.diseaseAbdominal aortic aneurysmSurgeryBlood Vessel ProsthesisTreatment Outcomecardiovascular systemaneurysmREPORTING STANDARDSSurgeryStentsCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalJournal of Endovascular Therapy
researchProduct

Similarly increased congenital anomaly rates after intrauterine insemination and IVF technologies: a retrospective cohort study

2012

International audience; BACKGROUND: While intrauterine insemination (IUI), a simple, inexpensive and non-invasive technique, is the most used assisted reproduction technology (ART) worldwide, the risk of major birth defects following IUI is paradoxically not well documented. METHODS: Retrospective cohort study performed in Burgundy, France, over a 9-year period which consisted of the cross analysis of two prospective databases, the Burgundy perinatal network database and the database of the assisted conception units in Burgundy. A total of 1348 ART singletons [in vitro fertilization technologies (IVFT): n= 903; IUI: n= 445] matched with 4044 infants conceived naturally, 552 ART twins (IVFT:…

medicine.medical_specialtymedicine.medical_treatment[ SDV.MHEP.PED ] Life Sciences [q-bio]/Human health and pathology/PediatricsFertilization in VitroBiologyInseminationInseminationCongenital Abnormalities03 medical and health sciences0302 clinical medicinePregnancyRisk FactorsmedicineConfidence IntervalsOdds RatioPrevalenceHumans030212 general & internal medicineInsemination ArtificialRetrospective StudiesGynecologyPregnancy[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics030219 obstetrics & reproductive medicineIntrauterine inseminationArtificial inseminationRehabilitationObstetrics and GynecologyCongenital malformationsRetrospective cohort studyOdds ratiomedicine.diseaseConfidence intervalReproductive MedicineArtificialFemale
researchProduct

Smoking and Neuropsychiatric Disease-Associations and Underlying Mechanisms.

2021

Despite extensive efforts to combat cigarette smoking/tobacco use, it still remains a leading cause of global morbidity and mortality, killing more than eight million people each year. While tobacco smoking is a major risk factor for non-communicable diseases related to the four main groups—cardiovascular disease, cancer, chronic lung disease, and diabetes—its impact on neuropsychiatric risk is rather elusive. The aim of this review article is to emphasize the importance of smoking as a potential risk factor for neuropsychiatric disease and to identify central pathophysiological mechanisms that may contribute to this relationship. There is strong evidence from epidemiological and experiment…

medicine.medical_specialtyneuropsychiatric disorder ; smoking ; smoking-induced disease ; inflammation ; oxidative stressQH301-705.5DiseaseReviewCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineRisk FactorsEpidemiologymedicineTobacco SmokingDementiaAnimalsHumans030212 general & internal medicinePhysical and Theoretical ChemistryCognitive declineRisk factorBiology (General)PsychiatryMolecular BiologyQD1-999SpectroscopyDepression (differential diagnoses)business.industryOrganic ChemistrySmokingsmoking-induced diseaseneuropsychiatric disorderGeneral Medicinemedicine.diseaseAnxiety DisordersComputer Science ApplicationsChemistryOxidative StressSchizophreniainflammationbusiness030217 neurology & neurosurgeryAnxiety disorderSignal TransductionInternational journal of molecular sciences
researchProduct

Health(care) in the Crisis: Reflections in Science and Society on Opioid Addiction

2021

Opioid abuse and misuse have led to an epidemic which is currently spreading worldwide. Since the number of opioid overdoses is still increasing, it is becoming obvious that current rather unsystematic approaches to tackle this health problem are not effective. This review suggests that fighting the opioid epidemic requires a structured public health approach. Therefore, it is important to consider not only scientific and biomedical perspectives, but societal implications and the lived experience of groups at risk as well. Hence, this review evaluates the risk factors associated with opioid overdoses and investigates the rates of chronic opioid misuse, particularly in the context of chronic…

medicine.medical_specialtypatient narrativesHealth Toxicology and Mutagenesismedia_common.quotation_subjectlcsh:MedicineContext (language use)ReviewOxyContinopioid abuse03 medical and health sciences0302 clinical medicineHealth caremedicineHumansSocial inequality030212 general & internal medicineOpioid EpidemicPsychiatrymedia_commonbusiness.industryPublic healthAddictionlcsh:RPublic Health Environmental and Occupational HealthOpioid-Related DisordersChronic painmedicine.diseaseOpioid-Related DisordersAnalgesics OpioidBehavior AddictiveOpioidSocioeconomic Factorsbusinesschronic pain030217 neurology & neurosurgerymedicine.drugInternational Journal of Environmental Research and Public Health
researchProduct